VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases.
VisiRose has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
VisiRose is headquartered in Knoxville, United States.
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases.
VisiRose is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VisiRose — Funding & Investors." VCBacked, January 14, 2025, https://www.vcbacked.co/company/visirose. Accessed September 17, 2026.
VCBacked. (2025). VisiRose — Funding & Investors. Retrieved September 17, 2026, from https://www.vcbacked.co/company/visirose
{{cite web |title=VisiRose — Funding & Investors |url=https://www.vcbacked.co/company/visirose |website=VCBacked |access-date=September 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated